KAREN SECOR: Open Payments
NPI 1437117280 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,518 in 68 payments from 24 companies in 2025. Trend: 2023 $1,855 · 2024 $1,816 · 2025 $1,518
Food & beverage: $1,343Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $216 |
| Amgen Inc. | 7 | $215 |
| SANOFI-AVENTIS U.S. LLC | 4 | $120 |
| Xeris Pharmaceuticals, Inc. | 5 | $116 |
| Ascendis Pharma Endocrinology Inc | 5 | $97 |
| Mannkind Corporation | 4 | $89 |
| TOLMAR, INC. | 3 | $68 |
| ABBVIE INC. | 4 | $62 |
| Sequel Med Tech, LLC | 3 | $61 |
| Alexion Pharmaceuticals, Inc. | 3 | $59 |
Products named: PROLIA, TZIELD, Rybelsus, RECORLEV, AFREZZA, Ozempic, FENSOLVI, LUPRON DEPOT.
Industry payments across GA — which companies pay providers there.
